好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Eye Movement Abnormalities in CNS Germ Cell Tumors
Neuro-oncology
P1 - Poster Session 1 (5:30 PM-6:30 PM)
7-027

To demonstrate eye movement abnormalities of 2 patients with CNS non-germinomatous germ cell tumors.


Neuro-ophthalmologic findings offer a means to localize an underlying brain lesion, complement neuroimaging findings and help in the diagnosis and management of neurological disorders.  Several syndromic eye movement abnormalities have been described historically in patients with CNS tumors, particularly those in the suprasellar and pineal regions.

Patient A is a 42-year-old man with non-germinomatous germ cell tumor and a head MRI obtained at the time of diagnosis in 2003 showed enhancements involving the bilateral ventricles, pineal area and suprasellar region.  He was treated with chemotherapy and craniospinal irradiation and that resulted in a complete response.  But he was left with persistent imbalance and seesaw nystagmus, with slow frequency alternating movements of one eye having elevation/intorsion and the other eye having synchronous depression/extorsion.

Patient B is a 23-year-old man who has a pineal region non-germinomatous germ cell tumor after presenting with obstructive hydrocephalus and Parinaud syndrome with restricted upgaze, convergence retraction nystagmus, eyelid retraction (Collier’s sign) and near-light dissociation.  His hydrocephalus was stabilized with a ventriculoperitoneal shunt.  He underwent 6 cycles of chemotherapy and achieved a radiographic partial response but without resolution of the Parinaud’s syndrome.


See-saw nystagmus is often localized to the rostral midbrain and has been associated with sellar/suprasellar space occupying lesions.  Parinaud syndrome localizes to pretectal lesions and has been associated with pineal region mass lesions with involvement of vertical gaze center in the dorsal midbrain.


Eye movement abnormalities can be extremely helpful in the localization of CNS tumors.  They are also useful for detecting clinical progression and alerting clinicians on the need for additional neuroimaging.
Authors/Disclosures
Sasmit Sarangi, MD, MBBS (Rhode Island Hospital/Brown University)
PRESENTER
The institution of Dr. Sarangi has received research support from Fore biotherapeutics.
Marc A. Bouffard, MD (Beth Israel Deaconess Medical Center) No disclosure on file
Eric T. Wong, MD, FAAN (Rhode Island Hospital) Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.